For the year ending 2025-12-31, ASMB has $257,590K in assets. $50,839K in debts. $58,450K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 58,450 | |||
| Marketable securities | 189,656 | |||
| Accounts receivable from collaboration with a related party | 974 | |||
| Prepaid expenses and other current assets | 5,469 | |||
| Total current assets | 254,549 | |||
| Property and equipment, net | 221 | |||
| Operating lease right-of-use (rou) assets | 2,508 | |||
| Other assets | 312 | |||
| Total assets | 257,590 | |||
| Accounts payable | 1,171 | |||
| Accrued research and development expenses | 2,387 | |||
| Other accrued expenses | 7,749 | |||
| Deferred revenue from a related party - short-term | 36,904 | |||
| Operating lease liabilities - short-term | 569 | |||
| Total current liabilities | 48,780 | |||
| Deferred revenue from a related party - long-term | 0 | |||
| Operating lease liabilities - long-term | 2,059 | |||
| Total liabilities | 50,839 | |||
| Common stock, 0.001 par value 150,000,000 shares authorized as of december 31, 2025 and december 31, 2024 15,855,329 and 7,457,240 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 16 | |||
| Additional paid-in capital | 1,038,823 | |||
| Accumulated other comprehensive loss | -41 | |||
| Accumulated deficit | -832,047 | |||
| Total stockholders' equity | 206,751 | |||
| Total liabilities and stockholders' equity | 257,590 | |||
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)